Polyclonal Antibody to Acyl Coenzyme A Synthetase Long Chain Family, Member 1 (ACSL1)
| Code | Size | Price |
|---|
| PAD671Mu01-20ul | 20ul | £90.00 |
Quantity:
| PAD671Mu01-100ul | 100ul | £169.00 |
Quantity:
| PAD671Mu01-200ul | 200ul | £229.00 |
Quantity:
| PAD671Mu01-1ml | 1ml | £526.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Applications:
- Immunocytochemistry (ICC)
- Immunohistochemistry (IHC)
- Immunoprecipitation (IP)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
ACS1; FACL1; FACL2; LACS; LACS1; LACS2; Fatty-Acid-Coenzyme A Ligase,Long-Chain 2; Lignoceroyl-CoA Synthase; Long-Chain Fatty-Acid-Coenzyme A Ligase 1
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Immunogen:
RPD671Mu01-Recombinant Acyl Coenzyme A Synthetase Long Chain Family, Member 1 (ACSL1)
Item Name:
Acyl Coenzyme A Synthetase Long Chain Family, Member 1
Reactivity:
Ra;
Source:
Polyclonal antibody preparation
Subcategory:
Polyclonal antibody preparation
USAGE:
Western blotting: 0.5-2ug/mL<br/>Immunohistochemistry: 5-20ug/mL<br/>Immunocytochemistry: 5-20ug/mL<br/>Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Acyl Coenzyme A Synthetase Long Chain Family, Member 1 (ACSL1) | RPD671Mu01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||